Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 14664
Country/Region: Nigeria
Year: 2017
Main Partner: Heartland Alliance
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $2,044,041 Additional Pipeline Funding: $2,484,937

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $188,022
Testing: HIV Testing and Counseling (HVCT) $899,515
Sexual Prevention: Other Sexual Prevention (HVOP) $506,557
Treatment: Adult Treatment (HTXS) $449,947
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 1,942
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 832
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 1,942
GEND_GBV Number of people receiving post-GBV care 2018 2,774
HTS_TST By Key Population: FSW, Negative 2018 68,780
HTS_TST By Key Population: MSM, Negative 2018 29,906
HTS_TST By Key Population: PWID, Negative 2018 994
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 110,944
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 68,578
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 31,102
HTS_TST Sum of Test Result disaggregates 2018 11,264
HTS_TST_POS By Key Population: FSW, Positive 2018 7,776
HTS_TST_POS By Key Population: MSM, Positive 2018 3,378
HTS_TST_POS By Key Population: PWID, Positive 2018 110
HTS_TST_POS By Test Result: Positive 2018 11,264
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 7,719
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 3,545
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 97,195
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 163
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 1,229
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 12,782
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 111,369
PrEP_NEW Female 15-19 2018 680
PrEP_NEW Female 20-24 2018 1,121
PrEP_NEW Female 25-49 2018 1,034
PrEP_NEW Female 50+ 2018 159
PrEP_NEW FSW 2018 2,994
PrEP_NEW Male 15-19 2018 355
PrEP_NEW Male 20-24 2018 585
PrEP_NEW Male 25-49 2018 303
PrEP_NEW Male 50+ 2018 37
PrEP_NEW MSM 2018 1,280
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2018 4,274
TX_CURR Aggregated Age/Sex: 15+ Female 2018 6,161
TX_CURR Aggregated Age/Sex: 15+ Male 2018 2,820
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 8,981
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 8,981
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 8,981
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 2,362
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,307
TX_NEW By Key populations: People who inject drugs (PWID) 2018 52
TX_NEW FSW 2018 2,314
TX_NEW MSM 2018 1,303
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,669
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 3,669
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 8,515
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 7,678
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 5,264
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,414
TX_PVLS Numerator: Indication: Targeted 2018 7,678
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 5,854
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,678
TX_PVLS_den Denominator: Indication: Targeted 2018 8,532
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 5,543
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,540
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 8,083
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 8,981
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,160
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,821
Cross Cutting Budget Categories and Known Amounts Total: $1,791,717
Gender: Gender Equality $118,489
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Based Violence (GBV) $1,035,825
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Key Populations: MSM and TG $52,040
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Conducting epidemiologic, social science, and operational research among MSM/TG and their sex partners
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $69,387
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs
Education $52,040
Human Resources for Health $63,936
Motor Vehicles: Purchased $400,000